Further analysis demonstrated that high IGFBP-3 expression was associated with an improved radiotherapy response in ESCC patients, with 83.3% of patients achieving complete response (CR) after radiotherapy for 3 months. The gene discussed is IGFBP3; the disease is esophageal squamous cell carcinoma.